Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL614563 Target Snapshot

COS-1 · CELL-LINE · Chlorocebus aethiops

191Compounds
36Assays
1Approved Drugs
65.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Confirm a stable target identifier before relying on this context across project surfaces.

Review focus
Open DB context pending

Confirm a stable target identifier before relying on this context across project surfaces.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats COS-1 as ChEMBL target CHEMBL614563. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
COS-1
CELL-LINE · Chlorocebus aethiops
As of 2026-09-13
ChEMBL target ID
CHEMBL614563
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether COS-1 still has a stable protein naming contract across sources.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCOS-1
UniProt AccessionN/A

COS-1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as COS-1.

Review nameCOS-1
OrganismChlorocebus aethiops
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5065.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL423680 7.3 IC50 50.0 Preclinical
CHEMBL92499 7.16 IC50 70.0 Preclinical
CHEMBL298734 7.12 IC50 75.0 Approved
CHEMBL88432 7.12 IC50 75.0 Preclinical
CHEMBL89304 7.07 IC50 85.0 Preclinical
CHEMBL88713 7.0 IC50 100.0 Preclinical
CHEMBL328713 7.0 IC50 100.0 Preclinical
CHEMBL313635 7.0 IC50 100.0 Preclinical
CHEMBL443022 6.96 IC50 110.0 Preclinical
CHEMBL90050 6.92 IC50 120.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
1
5.5
14
6.0
9
6.5
8
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LONAFARNIB
CHEMBL298734
Approved 2020
Assay Landscape

Assay Landscape

36
Total Assays
42
Tested Compounds
3
Assay Types
ADME — 22 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 22 16 4.7
Functional — 13 assays, 42 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 13 42 6.1
Toxicity — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine